Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Net Margin (2022 - 2025)

Bioregenx's Net Margin history spans 4 years, with the latest figure at 263.93% for Q4 2025.

  • Quarterly results put Net Margin at 263.93% for Q4 2025, up 373195.0% from a year ago — trailing twelve months through Dec 2025 was 83.23% (up 79734.0% YoY), and the annual figure for FY2025 was 83.23%, up 90194.0%.
  • Net Margin for Q4 2025 was 263.93% at Bioregenx, down from 15.87% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.46% in Q3 2023 to a low of 3995.88% in Q4 2024.
  • The 4-year median for Net Margin is 64.17% (2022), against an average of 352.52%.
  • The sharpest move saw Net Margin crashed -388969bps in 2024, then surged 373195bps in 2025.
  • Year by year, Net Margin stood at 62.09% in 2022, then tumbled by -71bps to 106.19% in 2023, then crashed by -3663bps to 3995.88% in 2024, then soared by 93bps to 263.93% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 263.93%, 15.87%, and 39.99% for Q4 2025, Q3 2025, and Q2 2025 respectively.